IONIS PHARMACEUT reported $-59154000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Agios Pharmaceuticals AGIO:US USD -86647000 8.29M
Alnylam Pharmaceuticals ALNY:US USD -334626000 142.94M
Arrowhead Research ARWR:US USD -83830000 10.92M
Astellas Pharma 4503:JP JPY 86.74B 53.6B
Biocryst Pharmaceuticals BCRX:US USD -17445000 17.28M
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bluebird Bio BLUE:US USD -84781000 22.62M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
Exelixis EXEL:US USD 82.61M 1.09M
Halozyme Therapeutics HALO:US USD 80.58M 46.52M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Moderna Inc MRNA:US USD 1.17B 1.28B
Nektar Therapeutics NKTR:US USD -54301000 98.54M
Neurocrine Biosciences NBIX:US USD 87.8M 103.1M
Novartis NOVN:VX USD 2.17B 60M
Omeros OMER:US USD -50766000 13.33M
Pfizer PFE:US USD 9.41B 2.69B
Ptc Therapeutics PTCT:US USD -68187000 24.17M
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Sarepta Therapeutics SRPT:US USD -256796000 45.66M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Vertex Pharmaceuticals VRTX:US USD 1.13B 20.4M